ArticleFrontiers in surgery2022

Programmed cell death 1 inhibitor plus chemotherapy vs. chemotherapy in advanced drive-gene-negative non-small-cell lung cancer patients: A real-world study.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.